Skip to main content

Table 2 Univariate and multivariate analysis of factors related to clinical success

From: Carbapenem alternatives for treatment of bloodstream infections due to AmpC producing enterobacterales

 

Clinical success

(n = 67)

RR (95% CI)

p

OR (95%CI)

p

Age ≥ 70 years

 

0.9 (0.73–0.98)

0.083

0.08 (0.007–0.966)

0.047

 - Yes

 - No

40 (82)

27 (96)

    

Heart failure

 

0.8 (0.42–1.33)

0.172

0.45 (0.066–3.095)

0.419

 - Yes

 - No

4 (67)

63 (89)

    

Charlson index > 3

 

0.8 (0.69–1.02)

0.083

0.16 (0.026–0.984)

0.048

 - Yes

 - No

25 (78)

42 (93)

    

CEF/P-T

 

1.2 (0.92–1.50)

0.138

7.75 (1.273–47.223)

0.026

 - Yes

 - No

50 (91)

17 (77)

    
  1. Note: CEF, cefepime; P-T, piperacillin-tazobatam